Tim Smith is an Assistant Editor at MJH Life Sciences. He focuses on themes related to medicine and healthcare, finance, and business economics, with particular interests in commodities markets and economic policy. Tim's work has been featured in notable publications including Commercial Observer, The Telegraph, and Bloomberg News.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Tim Smith's articles predominantly focus on healthcare and pharmaceuticals, specifically dermatology, medical research, FDA approvals, skin conditions, and allergies. His content heavily relies on data citations for credibility.
If reaching out to Tim with a pitch or as a source, ensure that the information provided is backed by credible data and scientific evidence. Experts in dermatology, medical researchers specializing in skin conditions and allergies may find success in pitching insights related to new findings or treatment approaches supported by robust data.
Given the absence of geographic focus in Tim's coverage attributes makes it clear that he covers topics from a global perspective without specific regional constraints.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Tim Smith
LEADderm 2026 brings dermatology leaders to Newport Beach, California, August 29-30, for sessions on leadership, AI in education, and career growth.
By: Tim Smith
The approval adds brepocitinib (Lisraya), an oral JAK/TYK2 inhibitor, as the first agent specifically studied and approved for dermatomyositis in adults.
AUD/USD trades near a three-month high as hot Australian inflation fuels RBA rate hike bets.
By: Tim Smith
East Midlands Chamber has said one of its longstanding calls to Government – getting greater devolved powers for Leicester and Leicestershire – has taken a ‘significant leap forward' after councils in the city, county and Rutland called for a regional mayor in a letter to ministers.
A recap of 7 standout interviews from LEADderm 2026, covering molluscum care, HS pipeline data, precision medicine, and dermatology leadership.
By: Tim Smith
With high business costs and increased regulatory pressure adding to a tough trading climate, the region's firms joined academic experts to address carbon footprint reduction and Corporate and Social Responsibility approaches at the East Midlands Sustainability and CSR Conference 2026.
By: Tim Smith
Annual Tipp Festival Celebrates 250 Years of American Independence If it's September, it must be time for the annual Tipp City Mum Festival.
AUD/USD has broken its ascending channel as Fed hike odds rise to 71%. US CPI could trigger further losses or an oversold rebound.
AUD/USD broke key support as rising US producer prices fueled bets on a Federal Reserve rate hike.
By: Tim Smith
has said the Autumn Budget on 28 th October needs to ease pressure on business, despite monthly GDP data from the Office for National Statistics showing unexpected growth to 0.4% in July, from 0.3% in June.
